ACL TOP Family 50 Series (ACL TOP 750 and 4 more
Instrument, Coagulation, Automated. 510(k) K242127, from Instrumentation Laboratory (IL) Co. (Bedford, MA). Product code GKP, class 2.
As of Nov 17, 2026, K242127 is an FDA 510(k) held by Instrumentation Laboratory (IL) Co., substantially equivalent on Aug 16, 2024 after 28 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Aug 16, 2024
- Review time: 28 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe ACL TOP Family 50 Series (ACL TOP 750; ACL TOP 750 CTS; ACL TOP 750 LAS; ACL TOP 550 CTS; ACL TOP 350 CTS) are bench top, fully automated, random access analyzers designed specifically for in vitro diagnostic clinical use in the hemostasis laboratory for coagulation and/or fibrinolysis testing in the assessment of thrombosis and/or hemostasis.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Acl Top Family 50 Series: Acl Top 350 Cts; Acl Top 550 Cts; Acl Top 750; Acl Top 750 Cts;…K150877 · Instrumentation Laboratory CO · Dec 13, 2015
Other GKP Clearances
The newest 510(k)s for the same product code; see every GKP device- ACL TOP Family 70 SeriesK231031 · Instrumentation Laboratory Company · Jun 21, 2023
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jul 19, 2024
- Review panel
- Hematology
- Regulation
- 21 CFR 864.5400
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files